Fate Therapeutics
FATE
#9566
Rank
A$0.16 B
Marketcap
A$1.39
Share price
-9.01%
Change (1 day)
-12.94%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2026 (TTM): A-$1.55

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$1.59. In 2025 the company made an earnings per share (EPS) of A-$1.74 an increase over its 2024 EPS that were of A-$2.48.

EPS history for Fate Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.55-10.85%
2025A-$1.74-29.88%
2024A-$2.48
2022A-$4.4030.49%
2021A-$3.377.21%
2020A-$3.1445.45%
2019A-$2.1619.17%
2018A-$1.8117.65%
2017A-$1.54-3.77%
2016A-$1.60-12.4%
2015A-$1.83-3.97%
2014A-$1.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Becton Dickinson
BDX
A$5.44-442.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A-$3.97 150.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A-$1.98 24.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$10.53-763.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A-$6.32 298.10%๐Ÿ‡บ๐Ÿ‡ธ USA